HCA Investigations No Harm to its Finances
HCA's latest settlement with the DOJ is the latest hit to the for-profit hospital chain, which, just a month ago, disclosed to investors on a second quarter earnings call that it was under a federal investigation by the DOJ for cardiac procedures performed at hospitals in Florida.
On the call, HCA pre-empted a New York Times investigation into its care of the indigent population and payment of ER doctors. That federal probe is ongoing and is unrelated to Wednesday's settlement. HCA stock closed down the day after the August 6th second quarter earnings call, but since then its stock price has risen by $6.96 per share.
"They're in very strong position, financially," says CRT's Skolnick. Perhaps because the company was only released from its eight-year CIA in 2009, she says she doesn't see evidence of a widespread problem at HCA. "The behaviors you learn while someone is watching your every move are hard to shake off," says Skolnick.
- 'Mega Boards' Could be Rural Healthcare Disruptor
- 12 Hires to Keep Your Hospital Out of Trouble
- 1 in 5 Eligible Hospitals Penalized for HACs
- Meaningful Use Payment Adjustments Begin
- HL20: Lee Aase—Who's Behind @MayoClinic
- Ratcheting Up Patient Experience Has a Downside
- No Boost to NFP Hospital Bond Ratings from Medicaid Expansion
- HL20: Peter Semczuk, DDS, MPH—Taking on the Big Challenges
- HL20: Rebecca Katz—Cooking Up Sustainable Nourishment
- Top 3 Nursing Lessons of 2014